248 related articles for article (PubMed ID: 3037152)
1. Mammary cancer stages in BALB/cV mice: mouse mammary tumor virus expression and virus-host interactions.
Slagle BL; Medina D; Butel JS
J Natl Cancer Inst; 1987 Aug; 79(2):323-35. PubMed ID: 3037152
[TBL] [Abstract][Full Text] [Related]
2. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
Slagle BL; Lanford RE; Medina D; Butel JS
Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
[TBL] [Abstract][Full Text] [Related]
3. A congenic line of the BALB/c mouse strain with the endogenous mouse mammary tumor virus proviral gene Mtv-3: tissue-specific expression and correlation with resistance to mouse mammary tumor virus infection and tumorigenesis.
Hainaut P; Castellazzi M; Gonzales D; Clausse N; Hilgers J; Crépin M
Cancer Res; 1990 Jun; 50(12):3754-60. PubMed ID: 2160325
[TBL] [Abstract][Full Text] [Related]
4. [Endogenous MMTV in the normal mammary gland and in dimethylanthracene-induced mammary cancer in BALB/c mice].
Komarova EA; Kriukova IN; Chernov MV; Kazarov AR
Mol Gen Mikrobiol Virusol; 1987 Aug; (8):10-3. PubMed ID: 2825005
[TBL] [Abstract][Full Text] [Related]
5. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
Squartini F; Basolo F; Bistocchi M
Cancer Res; 1983 Dec; 43(12 Pt 1):5879-82. PubMed ID: 6315219
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.
Slagle BL; Butel JS
Virology; 1985 May; 143(1):127-42. PubMed ID: 2997998
[TBL] [Abstract][Full Text] [Related]
7. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
8. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
[TBL] [Abstract][Full Text] [Related]
9. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo.
Tsubura A; Inaba M; Imai S; Murakami A; Oyaizu N; Yasumizu R; Ohnishi Y; Tanaka H; Morii S; Ikehara S
Cancer Res; 1988 Nov; 48(22):6555-9. PubMed ID: 2846153
[TBL] [Abstract][Full Text] [Related]
10. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.
McGrath CM; Jones RF
Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187
[TBL] [Abstract][Full Text] [Related]
11. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
12. B cell subsets in spleens of BALB/c mice: identification and isolation of MMTV-expressing and MMTV-responding subpopulations.
Lopez DM; Charyulu V; Paul RD
J Immunol; 1985 Jan; 134(1):603-7. PubMed ID: 2981095
[TBL] [Abstract][Full Text] [Related]
13. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
Ihle JN; Arthur LO; Fine DL
Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
Ritzi EM; Smith BA; Stolfi RL; Martin DS
Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
[TBL] [Abstract][Full Text] [Related]
15. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
16. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
Kang JJ; Schwegel T; Knepper JE
Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
[TBL] [Abstract][Full Text] [Related]
17. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
18. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
Thompson K
J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
[TBL] [Abstract][Full Text] [Related]
19. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
